Co-Diagnostics CEO on ramping up testing for COVID-19

Co-Diagnostics CEO Dwight Egan discusses a new FDA policy aimed at expediting the availablity of tests for the novel coronavirus, allowing the company to aggressively expand its presence in the U.S.